{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T05:56:45Z","timestamp":1794895005956,"version":"4.9.1"},"reference-count":77,"publisher":"Informa UK Limited","issue":"6","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Drug Safety"],"published-print":{"date-parts":[[2024,6,2]]},"DOI":"10.1080\/14740338.2024.2351462","type":"journal-article","created":{"date-parts":[[2024,5,3]],"date-time":"2024-05-03T08:57:21Z","timestamp":1714726641000},"page":"677-685","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":9,"title":["Efficacy and safety of deucravacitinib for the management of psoriasis: a drug safety evaluation"],"prefix":"10.1080","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5940-0592","authenticated-orcid":false,"given":"Luca","family":"Potestio","sequence":"first","affiliation":[{"name":"Section of Dermatology \u2013 Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nello","family":"Tommasino","sequence":"additional","affiliation":[{"name":"Section of Dermatology \u2013 Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Lauletta","sequence":"additional","affiliation":[{"name":"Section of Dermatology \u2013 Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Feo","sequence":"additional","affiliation":[{"name":"Section of Dermatology \u2013 Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Ruggiero","sequence":"additional","affiliation":[{"name":"Section of Dermatology \u2013 Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2523-050X","authenticated-orcid":false,"given":"Fabrizio","family":"Martora","sequence":"additional","affiliation":[{"name":"Section of Dermatology \u2013 Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Portarapillo","sequence":"additional","affiliation":[{"name":"Section of Dermatology \u2013 Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Guerriero","sequence":"additional","affiliation":[{"name":"Section of Dermatology \u2013 Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Megna","sequence":"additional","affiliation":[{"name":"Section of Dermatology \u2013 Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2024,5,6]]},"reference":[{"key":"e_1_3_6_3_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0052935"},{"key":"e_1_3_6_4_1","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2020.1746734"},{"key":"e_1_3_6_5_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.4006"},{"key":"e_1_3_6_6_1","doi-asserted-by":"publisher","DOI":"10.7861\/clinmed.2021-0257"},{"key":"e_1_3_6_7_1","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2012.339"},{"key":"e_1_3_6_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.12354"},{"key":"e_1_3_6_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.det.2020.12.014"},{"key":"e_1_3_6_10_1","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines9101482"},{"key":"e_1_3_6_11_1","doi-asserted-by":"publisher","DOI":"10.1080\/14712598.2022.2153593"},{"key":"e_1_3_6_13_1","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-3387"},{"key":"e_1_3_6_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2016.07.064"},{"key":"e_1_3_6_15_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20061475"},{"key":"e_1_3_6_16_1","doi-asserted-by":"publisher","DOI":"10.1080\/14740338.2022.2160447"},{"key":"e_1_3_6_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.14433"},{"key":"e_1_3_6_18_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1800013"},{"key":"e_1_3_6_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2017.07.004"},{"key":"e_1_3_6_20_1","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2012.167"},{"key":"e_1_3_6_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/dth.15667"},{"key":"e_1_3_6_22_1","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1243843"},{"key":"e_1_3_6_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/dth.15941"},{"key":"e_1_3_6_24_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12093233"},{"key":"e_1_3_6_25_1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaw1736"},{"key":"e_1_3_6_26_1","doi-asserted-by":"publisher","DOI":"10.1248\/bpb.b21-00609"},{"key":"e_1_3_6_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2016.12.005"},{"key":"e_1_3_6_28_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2015.167"},{"key":"e_1_3_6_29_1","doi-asserted-by":"publisher","DOI":"10.1080\/1744666X.2022.2008240"},{"issue":"5","key":"e_1_3_6_30_1","first-page":"S2","article-title":"Pathogenesis and treatment of psoriasis: exploiting pathophysiological pathways for precision medicine","volume":"33","author":"Alwan W","year":"2015","unstructured":"Alwan W, Nestle FO. Pathogenesis and treatment of psoriasis: exploiting pathophysiological pathways for precision medicine. Clin Exp Rheumatol. 2015;33(5 Suppl 93):S2\u20136.","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_3_6_31_1","doi-asserted-by":"publisher","DOI":"10.1080\/14740338.2023.2173171"},{"key":"e_1_3_6_32_1","doi-asserted-by":"publisher","DOI":"10.1080\/14740338.2023.2173170"},{"key":"e_1_3_6_33_1","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2019.1675855"},{"key":"e_1_3_6_34_1","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2019.1623371"},{"key":"e_1_3_6_35_1","doi-asserted-by":"publisher","DOI":"10.2147\/CCID.S423234"},{"key":"e_1_3_6_36_1","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.15543"},{"key":"e_1_3_6_37_1","doi-asserted-by":"publisher","DOI":"10.2174\/1574886315666200128095958"},{"key":"e_1_3_6_38_1","doi-asserted-by":"publisher","DOI":"10.1080\/14740338.2023.2173170"},{"key":"e_1_3_6_39_1","doi-asserted-by":"publisher","DOI":"10.1080\/14740338.2023.2173171"},{"key":"e_1_3_6_40_1","doi-asserted-by":"publisher","DOI":"10.1111\/ced.15395"},{"key":"e_1_3_6_41_1","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.27535"},{"key":"e_1_3_6_42_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-022-00689-y"},{"key":"e_1_3_6_43_1","doi-asserted-by":"publisher","DOI":"10.1111\/dth.15197"},{"key":"e_1_3_6_44_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.16926"},{"key":"e_1_3_6_45_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.16915"},{"key":"e_1_3_6_46_1","doi-asserted-by":"publisher","DOI":"10.1111\/dth.14261"},{"key":"e_1_3_6_47_1","doi-asserted-by":"publisher","DOI":"10.2147\/PTT.S407647"},{"key":"e_1_3_6_48_1","doi-asserted-by":"publisher","DOI":"10.1080\/14728214.2020.1745773"},{"key":"e_1_3_6_49_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-021-00649-y"},{"key":"e_1_3_6_50_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.9b00444"},{"key":"e_1_3_6_51_1","unstructured":"Gillooly K Zhang Y Yang X et al. BMS-986165 is a highly potent and selective allosteric inhibitor of Tyk2 blocks IL-12 IL-23 and type I interferon signaling and provides for robust efficacy in preclinical models of systemic lupus erythematosus an."},{"key":"e_1_3_6_52_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1901477"},{"key":"e_1_3_6_53_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-017-0701-9"},{"key":"e_1_3_6_54_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-021-00596-8"},{"key":"e_1_3_6_55_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrd.2017.201"},{"key":"e_1_3_6_56_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12082865"},{"key":"e_1_3_6_57_1","doi-asserted-by":"publisher","DOI":"10.3390\/medicina59040801"},{"key":"e_1_3_6_58_1","unstructured":"Myers Squibb B. SOTYKTUTM (deucravacitinib) tablets for oral use: US prescribing information. 2022 [cited 2023 Nov 12]. Available from: https:\/\/packageinserts.bms.com\/pi\/pi_sotyktu.pdf"},{"key":"e_1_3_6_59_1","unstructured":"Chimalakonda A Singhal S Dockens R et al. Deucravacitinib a selective tyrosine kinase 2 (TYK2) inhibitor: overview of clinical pharmacology including ADME food and pH effects pharmacokinetics in special populations and drug-drug inter- actions."},{"key":"e_1_3_6_60_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1806382"},{"key":"e_1_3_6_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2022.07.002"},{"key":"e_1_3_6_62_1","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.16740"},{"key":"e_1_3_6_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2022.08.061"},{"key":"e_1_3_6_64_1","unstructured":"Myers Squibb B. Sotyktu (deucravacitinib) long-term data demonstrate durable efficacy and consistent safety for up to three years in moderate-to-severe plaque psoriasis [media release]. 2023. [cited Nov 19]. Available from: http:\/\/www.bms.com"},{"key":"e_1_3_6_65_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-023-00977-1"},{"key":"e_1_3_6_66_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-023-01034-7"},{"key":"e_1_3_6_67_1","unstructured":"A study to evaluate the drug levels efficacy and safety of deucravacitinib in pediatric participants with moderate to severe plaque psoriasis. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04772079?cond=deucravacitinib+psoriasis&draw=2&rank=4.Ac"},{"key":"e_1_3_6_68_1","unstructured":"Efficacy and safety of deucravacitinib versus placebo in participants with moderate-to-severe scalp psoriasis. Available from [cited 2023 Nov 3]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT05478499?cond=deucravacitinib+psoriasis&draw=2&rank=2"},{"key":"e_1_3_6_69_1","unstructured":"An investigator initiated open label study evaluating the efficacy and tolerability of oral deucravacitinib for the treatment of nail psoriasis. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT05124080?cond=deucravacitinib+psoriasis&draw=2&rank=5.A"},{"key":"e_1_3_6_70_1","unstructured":"Deucravacitinib for the treatment of palmoplantar pustulosis. [cited 2023 Nov 19]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT05710185?cond=deucravacitinib+psoriasis&draw=2&rank=8"},{"key":"e_1_3_6_71_1","doi-asserted-by":"publisher","DOI":"10.2147\/CCID.S407813"},{"key":"e_1_3_6_72_1","doi-asserted-by":"publisher","DOI":"10.1080\/14712598.2022.2089020"},{"key":"e_1_3_6_73_1","doi-asserted-by":"publisher","DOI":"10.23736\/S2784-8671.21.07132-2"},{"key":"e_1_3_6_74_1","doi-asserted-by":"publisher","DOI":"10.1080\/14740338.2023.2218086"},{"key":"e_1_3_6_75_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2015.0718"},{"key":"e_1_3_6_76_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2018.09.042"},{"key":"e_1_3_6_77_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-020-01261-8"},{"key":"e_1_3_6_78_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2022-eular.2445"},{"key":"e_1_3_6_79_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2021-221664"},{"key":"e_1_3_6_80_1","unstructured":"SOTYKTU US. Prescribing information. [cited 2023 Nov 19]. Available from https:\/\/packageinserts.bms.com\/pi\/pi_sotyktu.pdf"}],"container-title":["Expert Opinion on Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14740338.2024.2351462","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,25]],"date-time":"2024-09-25T02:03:13Z","timestamp":1727229793000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14740338.2024.2351462"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,6]]},"references-count":77,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6,2]]}},"alternative-id":["10.1080\/14740338.2024.2351462"],"URL":"https:\/\/doi.org\/10.1080\/14740338.2024.2351462","relation":{},"ISSN":["1474-0338","1744-764X"],"issn-type":[{"value":"1474-0338","type":"print"},{"value":"1744-764X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,6]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieds20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieds20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2023-12-11","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-05-01","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-05-06","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}